Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ mTNBC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03838367
Recruitment Status : Recruiting
First Posted : February 12, 2019
Last Update Posted : February 28, 2020
Sponsor:
Collaborator:
Amarex Clinical Research
Information provided by (Responsible Party):
CytoDyn, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2022